Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

 

Hiroshi Yamada | Neuroscience | Excellence in Innovation

Mr. Hiroshi Yamada | Neuroscience | Excellence in Innovation

Mr. Hiroshi Yamada, Medical/Tsukuba, Japan.

H. Yamada, born in Kasugai, Aichi, Japan, has built an impressive academic and professional career in neuroscience. After earning his Bachelor of Science from Tohoku University, he pursued a Master’s degree at Osaka University and later obtained his Ph.D. from Kyoto Prefectural University of Medicine. His research journey took him from postdoctoral studies in Japan to New York University, where he collaborated with renowned neuroscientist Paul W. Glimcher. Returning to Japan, he served as Section Chief at the National Center of Neurology and Psychiatry before joining the University of Tsukuba, where he progressed from Assistant Professor to Associate Professor. His research focuses on neural mechanisms, contributing significantly to neuroscience through both theoretical and practical advancements.

Profile

Google Scholar

🎓 Early Academic Pursuits

H. Yamada’s academic journey reflects a deep-rooted passion for science and medicine. Born on September 9, 1977, in Kasugai, Aichi, Japan, he pursued a Bachelor of Science degree from the Faculty of Science at Tohoku University, graduating in 2000. Driven by a desire to deepen his understanding of human biology, he earned his Master of Arts from the Faculty of Medicine at Osaka University in 2002. His academic pursuits culminated in a Ph.D. from the Graduate School of Kyoto Prefectural University of Medicine in 2005, where he laid the groundwork for his future research in neuroscience.

🧠 Professional Endeavors in Neuroscience

H. Yamada’s professional career began with postdoctoral research at Kyoto Prefectural University of Medicine under the mentorship of Minoru Kimura, focusing on advanced neurological studies. His pursuit of global scientific exposure led him to New York University in 2008, where he worked with renowned neuroscientist Paul W. Glimcher. Upon returning to Japan, Yamada took on a leadership role as Section Chief at the National Center of Neurology and Psychiatry, National Institute of Neuroscience, from 2011. This role was pivotal in shaping his expertise in neurological research, ultimately leading to his tenure as Assistant Professor at the University of Tsukuba in 2013, and later as Associate Professor in 2022.

🔬 Contributions and Research Focus

Throughout his career, H. Yamada has been dedicated to unraveling the complexities of the human brain. His research primarily focuses on neuroscience, exploring neural mechanisms underlying behavior and cognition. At the University of Tsukuba, he has contributed significantly to the understanding of brain functions, merging experimental data with theoretical models to advance the field. His collaborations with international experts have enriched his approach, making his work both diverse and impactful.

🏅 Accolades and Recognition

Yamada’s contributions to neuroscience have earned him recognition within the academic community. His leadership roles and tenured position at the University of Tsukuba reflect his outstanding research and teaching capabilities. His work at prestigious institutions like New York University and the National Center of Neurology and Psychiatry has further solidified his reputation as a respected neuroscientist, contributing to both national and international scientific advancements.

🌍 Impact and Influence

H. Yamada’s research has had a profound impact on the field of neuroscience, influencing both academic circles and clinical practices. His studies on neural behavior have provided insights that bridge the gap between theoretical neuroscience and practical applications, aiding in the development of treatments for neurological disorders. As an educator, he has mentored numerous students, fostering the next generation of neuroscientists.

🚀 Legacy and Future Contributions

Looking ahead, H. Yamada is committed to expanding the horizons of neuroscience through innovative research and global collaborations. His legacy is not only reflected in his published work but also in the students and researchers he has inspired. As he continues his journey at the University of Tsukuba, his focus remains on advancing scientific knowledge and contributing to the global understanding of the human brain.

💡 A Lifelong Dedication to Science

H. Yamada’s life is a testament to the power of curiosity and dedication. From his early academic days in Tohoku to his current role as an Associate Professor, he has consistently pursued excellence in neuroscience. His journey underscores the importance of interdisciplinary research, mentorship, and the relentless quest for knowledge, leaving a lasting mark on the scientific community.

Publication

  • Title: Tonically active neurons in the primate caudate nucleus and putamen differentially encode instructed motivational outcomes of action
    Authors: H. Yamada, N. Matsumoto, M. Kimura
    Year: 2004

 

  • Title: Roles of the lateral habenula and anterior cingulate cortex in negative outcome monitoring and behavioral adjustment in nonhuman primates
    Authors: T. Kawai, H. Yamada, N. Sato, M. Takada, M. Matsumoto
    Year: 2015

 

  • Title: Thirst-dependent risk preferences in monkeys identify a primitive form of wealth
    Authors: H. Yamada, A. Tymula, K. Louie, P.W. Glimcher
    Year: 2013

 

  • Title: Juxtacellular labeling of tonically active neurons and phasically active neurons in the rat striatum
    Authors: H. Inokawa, H. Yamada, N. Matsumoto, M. Muranishi, M. Kimura
    Year: 2010

 

  • Title: Free choice shapes normalized value signals in medial orbitofrontal cortex
    Authors: H. Yamada, K. Louie, A. Tymula, P.W. Glimcher
    Year: 2018

 

  • Title: Tonically active neurons in the striatum encode motivational contexts of action
    Authors: M. Kimura, H. Yamada, N. Matsumoto
    Year: 2003

 

  • Title: Tonic firing mode of midbrain dopamine neurons continuously tracks reward values changing moment-by-moment
    Authors: Y. Wang, O. Toyoshima, J. Kunimatsu, H. Yamada, M. Matsumoto
    Year: 2021

 

  • Title: Roles of centromedian parafascicular nuclei of thalamus and cholinergic interneurons in the dorsal striatum in associative learning of environmental events
    Authors: K. Yamanaka, Y. Hori, T. Minamimoto, H. Yamada, N. Matsumoto, et al.
    Year: 2018

 

  • Title: Inactivation of the putamen selectively impairs reward history-based action selection
    Authors: M. Muranishi, H. Inokawa, H. Yamada, Y. Ueda, N. Matsumoto, M. Nakagawa, et al.
    Year: 2011

 

  • Title: Goal-directed, serial and synchronous activation of neurons in the primate striatum
    Authors: M. Kimura, N. Matsumoto, K. Okahashi, Y. Ueda, T. Satoh, T. Minamimoto, et al.
    Year: 2003

 

Conclusion

H. Yamada’s career is a reflection of his dedication to advancing the understanding of the human brain. His academic achievements, leadership roles, and research contributions have left a lasting impact on the neuroscience community. As he continues his work at the University of Tsukuba, his legacy is defined not only by his scientific discoveries but also by his mentorship and influence on future generations of researchers. His journey stands as an inspiring example of the pursuit of knowledge and the transformative power of science.

Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Assist Prof Dr. Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Assist Prof Dr. Nawal Al-Subaie,  Princess Noura University, Saudi Arabia

Nawal Al Subaie is a dedicated Clinical Pharmacist with extensive experience in clinical and academic roles at esteemed institutions, including Prince Sultan Military Medical City (PSMMC) and Princess Noura University (PNU). She holds a PhD in Clinical Pharmacy from DMU, UK, and a Master’s in International Practice and Policy from UCL, London. With a career spanning leadership, clinical care, and education, she has made significant contributions to pharmacy practice, quality control, and chronic disease management. Her commitment to continuous learning is reflected in numerous specialized courses and symposiums, along with frequent contributions to global conferences.

 

profile

scholor

🎓 Educational Background

PhD in Clinical Pharmacy,DMU Leicester, United Kingdom.MSc in Clinical Pharmacy (International Practice and Policy)
,UCL School of Pharmacy, London, United Kingdom.Bachelor’s Degree in Hospital Pharmacy,King Saud University, Riyadh, Saudi Arabia.

💼 Working Experience

Deputy in Charge of Pharmacy Division.Family and Community Medicine.Lead Pharmacist. Wazarat Health Centre (WHC).Clinical Pharmacist,Chronic Disease Clinic, WHC.Clinical Instructor / Trainer,Continuous education for pharmacy students at King Saud University, Princess Noura University, Northern Border University.Quality Control Representative Pharmacy, WHC.Part-time Lecturer,Clinical Ocular Pharmacology, King Saud University.JCI Accreditation Awardee,Primary Care Team.In-Charge of Clinical Pharmacist Ambulatory Care Clinics, PSMMC, 2020–2022.Assistant Professor,Princess Noura University (PNU), May 2022 – Present.

🏫 Training Courses / Symposiums

2015 – 2019: PhD Student (Diabetes and Exercise)Pharmacy School, DMU, UK.2014: TOT Course Leicester, UK.2016: Phlebotomy Course Nottingham, UK.2016: First Aid CourseLeicester, UK.2022: ASHP Diabetes Management Certificate Course January – December 2022.

🌍 Conferences Attended & Contributions

2024: Attended the 4th Saudi Society of Clinical Pharmacist Annual International Conference (September).2024: Presented Poster at Dubai International Pharmaceuticals and Technologies Conference.2023: Oral Presentation at Neurology Conference, Dubai (March).2023: Judge, Pharmacy Research Day, PNU Research Center (May).2022: Attended First Saudi Society of Clinical Pharmacist Annual International Conference (September)(and many more from 2000 to 2024)

🤲 Voluntary Work

University orientation for new students, DMU. Diabetes Awareness Day, in collaboration with Diabetes UK. Trained students at DMU on ELISA and Randox machine for blood sample analysis. Assisted pharmacy students with projects and dissertations, DMU

🏅 Professional Memberships

Saudi Commission for Health Specialties (ID: 09-R-P-0295492)

📚 Publications

  1. Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
    Authors: N. Alsubaie, H.M. Al-Kuraishy, A.I. Al-Gareeb, B. Alharbi, M. De Waard, …
    Year: 2022

 

  1. Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and β-glucogallin in the Management of Diabetic Retinopathy
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2023

 

  1. The Potential Therapeutic Effect of Metformin in Type 2 Diabetic Patients with Severe COVID-19
    Authors: H.M. Al-Kuraishy, A.I. Al-Gareeb, A.A. El Kholy, E. El-Khateeb, A. Alexiou, …
    Year: 2023

 

  1. The Effects of a Combined Exercise Programme Aerobic and Resistance on Blood Glucose, Incretin, Metabolic and Inflammatory Mediators that Could Control the Diabetes and Improve …
    Author: N. Alsubaie
    Year: 2019

 

  1. Corrigendum to “Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and β-glucogallin in the Management of Diabetic Retinopathy”
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2024

 

  1. Impact of Clinical Pharmacist Diabetes Clinic on the Improvement of Health Outcomes in Type 2 Diabetes Subjects
    Authors: N. AlSubaie, M. Alsallal, S. AlTwaijri, A. AlOtaibi, B. AlHarbi, M. AlEissa, …
    Year: 2022

 

  1. The Effects of a Combined Aerobic and Resistance Exercise Programme on Insulin Resistance Among Prediabetes Subjects
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: N. Alsubaie, B. Alharbi, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose, and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: B.M. Alharbi, N.S. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Impact of Moderate Combination Exercise on HbA1c, IL-6, and TNF in Type 2 Diabetic and Non-diabetic Subjects: An Interventional Non-randomized Clinical Trial
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

 Conclusion

Dr. Al Subaie’s career showcases a deep commitment to enhancing patient care, advancing pharmaceutical education, and contributing to international health discussions. Her background in both hands-on clinical care and academic research equips her with a well-rounded perspective, making her a valuable asset in clinical and educational settings alike. She continues to make strides in diabetes management, chronic disease care, and pharmacy education, with her work recognized through multiple presentations, awards, and professional memberships.